Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ee Lyn Lim

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Immunology|May 21, 2019
Phosphoinositide 3-kinase δ is a regulatory T-cell target in cancer immunotherapyEe Lyn Lim, Klaus Okkenhaug
Immunological Reviews|June 22, 2020
Control of foreign Ag-specific Ab responses by Treg and TfrJames B Wing, Ee Lyn Lim, Shimon Sakaguchi
European Journal of Immunology|October 7, 2025
Loss of PI3Kδ Activity Drives Autoimmune Colitis by Impairing Extrathymic Treg DifferentiationEe Lyn Lim, Yamin Qian, Fuminori Sugihara, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Associations between adipokines and obesity-related cancerGilberto Paz-Filho, Ee Lyn Lim, Ma-Li Wong, et al.
JCI Insight|June 8, 2018
Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitorsEe Lyn Lim, Fiorella M Cugliandolo, Dalya R Rosner, et al.
JCI Insight|June 8, 2018
Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapyDavid Gyori, Ee Lyn Lim, Francis M Grant, et al.
Nucleic Acids Research|December 6, 2011
GWASdb: a database for human genetic variants identified by genome-wide association studiesMulin Jun Li, Panwen Wang, Xiaorong Liu, et al.
Science Immunology|January 11, 2024
Disrupted degradative sorting of TLR7 is associated with human lupusHarshita Mishra, Claire Schlack-Leigers, Ee Lyn Lim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2018
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibodyDanbee Ha, Atsushi Tanaka, Tatsuya Kibayashi, et al.
Nature|June 12, 2014
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancerKhaled Ali, Dalya R Soond, Roberto Pineiro, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Immunology|May 21, 2019
Phosphoinositide 3-kinase δ is a regulatory T-cell target in cancer immunotherapyEe Lyn Lim, Klaus Okkenhaug
Immunological Reviews|June 22, 2020
Control of foreign Ag-specific Ab responses by Treg and TfrJames B Wing, Ee Lyn Lim, Shimon Sakaguchi
European Journal of Immunology|October 7, 2025
Loss of PI3Kδ Activity Drives Autoimmune Colitis by Impairing Extrathymic Treg DifferentiationEe Lyn Lim, Yamin Qian, Fuminori Sugihara, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Associations between adipokines and obesity-related cancerGilberto Paz-Filho, Ee Lyn Lim, Ma-Li Wong, et al.
JCI Insight|June 8, 2018
Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitorsEe Lyn Lim, Fiorella M Cugliandolo, Dalya R Rosner, et al.
JCI Insight|June 8, 2018
Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapyDavid Gyori, Ee Lyn Lim, Francis M Grant, et al.
Nucleic Acids Research|December 6, 2011
GWASdb: a database for human genetic variants identified by genome-wide association studiesMulin Jun Li, Panwen Wang, Xiaorong Liu, et al.
Science Immunology|January 11, 2024
Disrupted degradative sorting of TLR7 is associated with human lupusHarshita Mishra, Claire Schlack-Leigers, Ee Lyn Lim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2018
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibodyDanbee Ha, Atsushi Tanaka, Tatsuya Kibayashi, et al.
Nature|June 12, 2014
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancerKhaled Ali, Dalya R Soond, Roberto Pineiro, et al.
Pageof 2